Treatments:Cancer

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 6: Line 6:
* [[Rituxan]] - Generic: Rituximab
* [[Rituxan]] - Generic: Rituximab
=====Anti-melanoma [[Monoclonal Antibody]]=====
=====Anti-melanoma [[Monoclonal Antibody]]=====
-
* [[Pembrolizumab]] - Generic: [[Keytruda]]
+
* Pembrolizumab - Generic: [[Keytruda]]
=====B-Raf Kinase Inhibitor=====
=====B-Raf Kinase Inhibitor=====
* Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032)
* Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032)

Revision as of 08:05, 21 January 2019

Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
  • Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032)
Chemotherapy
  • Platinol - Generic: Cisplatin
Dihydrofolate Reductase Inhibitor
  • Alimta - Generic: Pemetrexed
  • Folotyn - Generic: Pralatrexate
  • Methotrexate
  • Raltitrexed
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
  • Evista - Generic: Raloxifene
  • Fareston - Generic: Toremifene
  • Nolvadex - Generic: Tamoxifen
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Michal Harel, Alexander Berchansky, Karsten Theis

Retrieved from "http://52.214.119.220/wiki/index.php/Treatments:Cancer"
Personal tools